Background Myocardial strain is a sensitive measure of ventricular systolic function. Two-dimensional speckle-tracking echocardiography (2DSE) is an angle-independent method for strain measurement but has not been validated in pediatric subjects. We evaluated the accuracy and reproducibility of 2DSE-measured strain against reference tagged MRI-measured strain in pediatric subjects with normal hearts and those with single ventricle (SV) of left ventricle (LV) morphology s/p Fontan procedure. Methods Peak systolic circumferential (CS) and longitudinal (LS) strains in segments (n = 16) of LVs in age and BSA matched 20 healthy and 12 pediatric subjects with tricuspid atresia s/p Fontan procedure were measured by 2DSE and tagged MRI. Average (global) and regional segmental strains measured by two methods were compared using Spearman and Bland-Altman analyses. Results 2DSE and tagged MRI measured global strains demonstrated close agreements, which were better for LS than CS and in normal LVs than in SVs (95% limits of agreement: +0.0% to +3.12%, −2.48 % to +1.08%, −4.6% to +1.8% and −3.6% to +1.8% respectively). There was variability in agreement between regional strains with wider limits in apical than in basal regions in normal LVs and heterogeneous in SVs. The strain values were significantly (p < 0.05) higher in normal LVs than in SVs except for basal LSs, which were similar in both cohorts. The regional strains in normal LVs demonstrated an apico-basal magnitude gradient whereas SVs showed heterogeneity. The reproducibility was the most robust for images obtained with frame rates between 60 and 90 frame/sec; global LS in both cohorts; and basal strains in normal LVs. Conclusions 2DSE-measured strains agree with MRI-measured strain globally but vary regionally particularly in SVs. Global strain may be more robust tool for the cardiac function evaluation than regional strain in SV physiology. The reliability of 2DSE measured strain is affected by the frame rate, nature of strain, and ventricular geometry.

No abstract

No abstract

High intensity focused ultrasound (HIFU) is an evolving technology with potential therapeutic applications. Utilizing frequencies of 500 kHz to 10 MHz, HIFU causes localized hyperthermia at predictable depths without injuring intervening tissue. Applications in neurosurgery, urology, oncology and, more recently, cardiology for selective cardiac conduction tissue ablation have been promising. A 'noninvasive' technique for causing localized tissue damage to relieve hemodynamic and life-threatening obstruction in patients with congenital cardiac anomalies could replace more invasive procedures. We, therefore, investigated the ability of HIFU to create lesions in mammalian cardiac tissues ex vivo. Porcine valve leaflet, canine pericardium, human newborn atrial septum, and right atrial appendage were studied. Specimens were mounted and immersed in a water bath at room temperature. Using a 1-MHz phased array transducer, ultrasound energy was applied with an acoustic intensity of 1630 W/cm(2) or 2547 W/cm(2) until a visible defect was created (duration 3 to 25 sec). Macroscopic and microscopic examination demonstrated precise defects ranging from 3 to 4 mm in diameter. No damage was identified to the surrounding tissues. Our study concluded that HIFU can create precise defects in different cardiac tissue without damage to the surrounding tissue. Further investigation is needed to assess potential clinical uses of this technology.

This paper reports the results of the initial animal studies of a wireless, batteryless, implantable pressure sensor using microelectromechanical systems (MEMS) technology. The animal studies were acute and proved the functional feasibility of using MEMS technology for wireless bio sensing. The results are very encouraging and surpassed the majority of the application's requirements, including high sampling speed and high resolution. Based on the lessons learned, second generation wireless sensors are being developed that will provide total system solution.